Atypical Antipsychotics Induced Metabolic Syndrome
The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in th...
| Auteurs principaux: | , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Psikiyatride Güncel Yaklaşımlar
2015-03-01
|
| Collection: | Psikiyatride Güncel Yaklaşımlar |
| Sujets: | |
| Accès en ligne: | http://www.cappsy.org/archives/vol7/no1/cap_07_01_07.pdf |